This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Roxanne Paula Spencer: Innovator in Pharmaceutical Manufacturing
Introduction
Roxanne Paula Spencer is a notable inventor in the field of pharmaceutical manufacturing. She has contributed to the development of methods for producing specific chemical compounds that are essential in the medical industry. Her work focuses on innovative processes that enhance the efficiency and effectiveness of drug manufacturing.
Latest Patents
Roxanne Paula Spencer holds a patent for a method for the manufacture of Anagrelide. This patent outlines methods for creating certain 6,7-dihalo-1,5-dihydroimidazo [2,1-b]quinazolin-2(3H)-ones from 2,3-dihalobenzaldehydes. Additionally, it provides a method for producing the intermediate ethyl N-(2,3-dihalo-6-nitrobenzyl)glycines from 2,3-dihalobenzaldehydes. The patent also describes a cyclization method to form the desired compounds from the corresponding iminquinazoline compounds. These methods are particularly suitable for the manufacture of Anagrelide base.
Career Highlights
Roxanne Paula Spencer has made significant strides in her career, particularly through her work at Shire US Inc. Her innovative approaches to chemical manufacturing have positioned her as a key figure in the pharmaceutical industry. Despite having no patents listed under her name, her contributions to the field are noteworthy.
Collaborations
Roxanne has collaborated with esteemed colleagues such as Michael Joseph Roth and Wen-Lung Yeh. These partnerships have further enhanced her research and development efforts in pharmaceutical manufacturing.
Conclusion
Roxanne Paula Spencer is a dedicated inventor whose work in pharmaceutical manufacturing has the potential to impact the industry significantly. Her innovative methods for producing essential compounds demonstrate her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile